This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Butler, J. Articles by Wilson, J. R. Search for Related Content PubMed PubMed Citation Articles by Butler, J. Articles by Wilson, J. R.

CLINICAL STUDIES

Pulmonary hypertension and exercise intolerance in patients with heart failure

^a Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Manuscript received October 14, 1998; revised manuscript received June 15, 1999, accepted August 6, 1999.

Reprint requests and correspondence: Dr. John R. Wilson, Division of Cardiology, 315 MRB II, Vanderbilt University Medical Center, Nashville, Tennessee 37232.
John.R.Wilson{at}Mcmail.vanderbilt.edu

OBJECTIVES

This study was undertaken to investigate the relationship between pulmonary hypertension and exercise performance in patients with heart failure.

BACKGROUND

The exercise capacity of patients with heart failure is frequently reduced. Pulmonary hypertension may contribute to this exercise intolerance by impairing blood flow through the pulmonary circulation.

METHOD

Three hundred twenty patients with heart failure underwent upright treadmill exercise testing with hemodynamic monitoring. The incidence of pulmonary hypertension and the relationship between pulmonary vascular resistance (PVR) and exercise cardiac output and minute oxygen consumption (VO₂) were examined.

RESULTS

Pulmonary vascular resistance was normal (<1.5 Wood Units; Group 1) in 28% of the patients, mildly elevated (1.5 to 2.49 Wood Units; Group 2) in 36%, moderately elevated (2.5 to 3.49 Wood Units; Group 3) in 17% and severely elevated (>3.5 Wood Units; Group 4) in 19%. Increasing PVR was associated with significantly lower peak exercise VO₂ (Group 1: 13.9 ± 3.7; 2:13.7 ± 3.4; 3: 11.8 ± 2.4; 4: 11.5 ± 2.6 L/min, p < 0.01 Groups 3 and 4 vs. 1) and lower peak exercise cardiac output (Group 1: 10.0 ± 2.8, 2:9.0 ± 3.0; 3: 7.4 ± 2.1; 4: 6.3 ± 2.0 L/min, p < 0.05, Groups 2, 3 and 4 vs. 1). The pulmonary wedge pressure decreased during exercise, consistent with impaired left ventricular filling, in 36% of patients with severe pulmonary hypertension (Group 4) versus only 13% of patients with normal PVR (p < 0.01).

CONCLUSIONS

Pulmonary vascular resistance is frequently increased in heart failure and is associated with a reduced cardiac output response to exercise, suggesting that pulmonary hypertension impairs exercise performance in heart failure.

Abbreviations and Acronyms   ANOVA = analysis of variance   O2 = oxygen   PVR = pulmonary vascular resistance   VO2 = minute oxygen consumption

This article has been cited by other articles:

				V. Melenovsky, H. Al-Hiti, L. Kazdova, A. Jabor, P. Syrovatka, I. Malek, J. Kettner, and J. Kautzner Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. J. Am. Coll. Cardiol., August 11, 2009; 54(7): 595 - 600. [Abstract] [Full Text] [PDF]

				G. D. Lewis The role of the pulmonary vasculature in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1127 - 1129. [Full Text] [PDF]

				J-W Ha, D Choi, S Park, C-Y Shim, J-M Kim, S-H Moon, H-J Lee, E-Y Choi, and N Chung Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction Heart, March 15, 2009; 95(6): 490 - 494. [Abstract] [Full Text] [PDF]

				G. D. Lewis, R. V. Shah, P. P. Pappagianopolas, D. M. Systrom, and M. J. Semigran Determinants of Ventilatory Efficiency in Heart Failure: The Role of Right Ventricular Performance and Pulmonary Vascular Tone Circ Heart Fail, November 1, 2008; 1(4): 227 - 233. [Abstract] [Full Text] [PDF]

				K. Albouaini, M. Egred, A. Alahmar, and D. J. Wright Cardiopulmonary exercise testing and its application Postgrad. Med. J., November 1, 2007; 83(985): 675 - 682. [Abstract] [Full Text] [PDF]

				G. D. Lewis, R. Shah, K. Shahzad, J. M. Camuso, P. P. Pappagianopoulos, J. Hung, A. Tawakol, R. E. Gerszten, D. M. Systrom, K. D. Bloch, et al. Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension Circulation, October 2, 2007; 116(14): 1555 - 1562. [Abstract] [Full Text] [PDF]

				K Albouaini, M Egred, A Alahmar, and D J Wright Cardiopulmonary exercise testing and its application Heart, October 1, 2007; 93(10): 1285 - 1292. [Abstract] [Full Text] [PDF]

				D. Merkus, B. Houweling, V. J. de Beer, Z. Everon, and D. J. Duncker Alterations in endothelial control of the pulmonary circulation in exercising swine with secondary pulmonary hypertension after myocardial infarction J. Physiol., May 1, 2007; 580(3): 907 - 923. [Abstract] [Full Text] [PDF]

				M. S. Ahmed, E. Oie, L. E. Vinge, T. G. von Lueder, T. Attramadal, and H. Attramadal Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling Cardiovasc Res, May 1, 2007; 74(2): 323 - 333. [Abstract] [Full Text] [PDF]

				D. Zimpfer, P. Zrunek, W. Roethy, M. Czerny, H. Schima, L. Huber, M. Grimm, A. Rajek, E. Wolner, and G. Wieselthaler Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 689 - 695. [Abstract] [Full Text] [PDF]

				G. Tumminello, P. Lancellotti, M. Lempereur, V. D'Orio, and L. A. Pierard Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure Eur. Heart J., March 1, 2007; 28(5): 569 - 574. [Abstract] [Full Text] [PDF]

				J.-F. Jasmin, I. Mercier, R. Hnasko, M. W.-C Cheung, H. B Tanowitz, J. Dupuis, and M. P Lisanti Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression Cardiovasc Res, September 1, 2004; 63(4): 747 - 755. [Abstract] [Full Text] [PDF]

				P. Agostoni, G. Cattadori, M. Bianchi, and K. Wasserman Exercise-Induced Pulmonary Edema in Heart Failure Circulation, November 25, 2003; 108(21): 2666 - 2671. [Abstract] [Full Text] [PDF]

				J.-F. Jasmin, A. Calderone, T.-K. Leung, L. Villeneuve, and J. Dupuis Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan Cardiovasc Res, June 1, 2003; 58(3): 621 - 631. [Abstract] [Full Text] [PDF]

				M. Nakamura, H. Yoshida, Y. Naganuma, H. Kon, S. Sugawara, and K. Hiramori Peripheral Vasodilatory Dysfunction in Adult Patients with Congenital Heart Disease and Severely Elevated Pulmonary Vascular Resistance Angiology, November 1, 2002; 53(6): 715 - 720. [Abstract] [PDF]

				D. L. Moraes, W. S. Colucci, and M. M. Givertz Secondary Pulmonary Hypertension in Chronic Heart Failure : The Role of the Endothelium in Pathophysiology and Management Circulation, October 3, 2000; 102(14): 1718 - 1723. [Abstract] [Full Text] [PDF]

				C. Rostagno, G. Galanti, M. Comeglio, V. Boddi, G. Olivo, and G. G. N. Serneri Comparison of different methods of functional evaluation in patients with chronic heart failure Eur J Heart Fail, September 1, 2000; 2(3): 273 - 280. [Abstract] [Full Text] [PDF]